Bank of America Corp DE Boosts Stock Holdings in ICU Medical, Inc. $ICUI

Key Points

• Bank of America increased its ICU Medical stake by 11.2% in the first quarter to 331,739 shares worth approximately $42.8 million. Institutional investors collectively own about 96.1% of the company.
• ICU Medical exceeded quarterly expectations, reporting EPS of $2.37 versus the $1.91 consensus and revenue of $547.88 million versus $533.44 million expected. Analysts raised price targets, with the consensus rating at “Moderate Buy” and an average target of $192.80.
• Insiders have been selling shares: the COO, a director and other insiders sold 11,557 shares worth roughly $2.1 million over three months. Shares opened at $179.34, below the 12-month high of $192.85, while the stock trades at a high P/E ratio of about 152.

Bank of America Corp DE raised its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 11.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 331,739 shares of the medical instruments supplier's stock after acquiring an additional 33,508 shares during the quarter. Bank of America Corp DE owned approximately 1.33% of ICU Medical worth $42,844,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Hilton Head Capital Partners LLC purchased a new stake in shares of ICU Medical during the fourth quarter worth $32,000. Covestor Ltd lifted its stake in shares of ICU Medical by 22.1% in the fourth quarter. Covestor Ltd now owns 696 shares of the medical instruments supplier's stock worth $99,000 after buying an additional 126 shares in the last quarter. Strs Ohio lifted its stake in shares of ICU Medical by 60.0% in the fourth quarter. Strs Ohio now owns 800 shares of the medical instruments supplier's stock worth $114,000 after buying an additional 300 shares in the last quarter. Rockefeller Capital Management L.P. boosted its position in ICU Medical by 21.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 823 shares of the medical instruments supplier's stock worth $117,000 after acquiring an additional 146 shares during the last quarter. Finally, Kemnay Advisory Services Inc. acquired a new position in ICU Medical during the fourth quarter worth about $120,000. Hedge funds and other institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

A number of analysts have commented on ICUI shares. Piper Sandler increased their price objective on shares of ICU Medical from $163.00 to $195.00 and gave the company an "overweight" rating in a report on Friday, August 7th. Zacks Research cut ICU Medical from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 28th. BTIG Research upped their price target on ICU Medical from $170.00 to $200.00 and gave the company a "buy" rating in a research report on Friday, August 7th. Wall Street Zen upgraded ICU Medical from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 8th. Finally, Needham & Company LLC increased their price target on ICU Medical from $165.00 to $187.00 and gave the company a "buy" rating in a report on Friday, August 7th. Two analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, ICU Medical currently has a consensus rating of "Moderate Buy" and an average price target of $192.80.

Insider Activity at ICU Medical

In related news, COO Christian B. Voigtlander sold 8,929 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $182.93, for a total value of $1,633,381.97. Following the completion of the transaction, the chief operating officer directly owned 37,377 shares in the company, valued at approximately $6,837,374.61. This represents a 19.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Elisha W. Finney sold 378 shares of the firm's stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $182.48, for a total value of $68,977.44. Following the sale, the director directly owned 4,871 shares of the company's stock, valued at approximately $888,860.08. This trade represents a 7.20% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 11,557 shares of company stock worth $2,103,579. Insiders own 2.10% of the company's stock.

Trending Headlines about ICU Medical

Here are the key news stories impacting ICU Medical this week:

• Positive Sentiment: Strong earnings and margin expansion support the investment case. ICU Medical’s latest quarterly results exceeded expectations, with EPS of $2.37 versus the $1.91 consensus and revenue of $547.88 million versus estimates of $533.44 million. A recent analysis also highlighted margin expansion and strength in the company’s infusion systems business. ICUI Q2 Deep Dive: Margin Expansion and Infusion Systems Drive Outperformance
• Positive Sentiment: Analysts raised price targets following the results. Needham lifted its target to $187, BTIG raised its target to $200, and Piper Sandler increased its target to $195 while maintaining an overweight rating. The consensus rating remains “Moderate Buy,” with an average price target of $192.80.
• Neutral Sentiment: Institutional ownership remains high. Several smaller investment firms recently initiated or increased positions in ICU Medical, while institutional investors and hedge funds collectively own approximately 96.1% of the shares. The reported short-interest data showed zero shares short, offering little indication of short-selling pressure.
• Negative Sentiment: Multiple insiders sold shares near recent highs. COO Christian B. Voigtlander sold 8,929 shares for approximately $1.63 million, CIO Ben Sousa sold 2,250 shares for about $401,000, and Director Elisha Finney sold 378 shares for roughly $69,000. The sales reduced their respective holdings by approximately 19.3%, 42.3% and 7.2%, potentially raising investor concerns about insider conviction. Top ICU Medical Executive Makes a Notable Move With Company Stock

ICU Medical Trading Down 1.5%

Shares of ICUI opened at $179.34 on Thursday. ICU Medical, Inc. has a 12-month low of $110.50 and a 12-month high of $192.85. The firm has a market capitalization of $4.48 billion, a P/E ratio of 151.98, a P/E/G ratio of 2.54 and a beta of 0.74. The firm has a 50-day moving average price of $154.67 and a 200 day moving average price of $141.46. The company has a current ratio of 2.43, a quick ratio of 1.21 and a debt-to-equity ratio of 0.56.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Thursday, August 6th. The medical instruments supplier reported $2.37 earnings per share for the quarter, beating the consensus estimate of $1.91 by $0.46. The company had revenue of $547.88 million for the quarter, compared to analyst estimates of $533.44 million. ICU Medical had a net margin of 1.39% and a return on equity of 7.91%. ICU Medical's revenue was up .5% on a year-over-year basis. During the same period in the previous year, the business posted $2.10 EPS. ICU Medical has set its FY 2026 guidance at 8.600-9.000 EPS. Sell-side analysts forecast that ICU Medical, Inc. will post 6.51 EPS for the current year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source